A promising area of research involves XmAb541 and CTIM-76, bsAbs targeting claudin-6 (CLDN6), a tight junction protein that is selectively expressed on cancer cells with little to no presence in normal healthy tissue [106]. The gene discussed is CLDN6; the disease is cancer.